New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

Participants in a new study who used GLP-1 drugs had a much lower cancer risk than those who had bariatric surgery.

WGN’s Dina Bair has the latest on new medical information, including: Study: Mounjaro helped people achieve more weight loss ...

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

Some of the bankrupt company’s closest rivals, newer telehealth firms, face a new challenge of their own as federal ...

A survey shows Gen Z favoring weight loss drugs like Ozempic and Wegovy over exercise and diet for reaching their weight loss ...

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.

Drugs like Ozempic — which mimic the appetite-suppressing GLP-1 hormone the body naturally produces after eating — have been ...

The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...